Characterization of the clinical features, laboratory findings, and outcomes of human fascioliasis in a global network: a retrospective mutlicenter study

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective study characterizes fascioliasis outcomes in a cohort of patients, highlighting comorbidities and symptoms.

High rates of comorbidities, including essential hypertension and heart disease, were found in fascioliasis patients.
The study cohort had 174 patients with significant symptoms like abdominal pain and fatigue, indicating underlying health issues.
Limited use of triclabendazole for treatment may be linked to accessibility issues in various countries.
Mortality within 90 days was low at less than 6%, yet liver and biliary complications require further investigation.

Henao‐Martínez et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark